Chemical aspects of metal ion chelation in the synthesis and application antibody-based radiotracers
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chemical aspects of metal ion chelation in the synthesis and application antibody-based radiotracers
Authors
Keywords
-
Journal
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2017-12-12
DOI
10.1002/jlcr.3590
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 213Bi-PSMA-617 targeted alpha-radionuclide therapy in metastatic castration-resistant prostate cancer
- (2017) Mike Sathekge et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Theranostics Using Antibodies and Antibody-Related Therapeutics
- (2017) Kirsten L. Moek et al. JOURNAL OF NUCLEAR MEDICINE
- Re-assessing gallium-67 as a therapeutic radionuclide
- (2017) Muhamad F. bin Othman et al. NUCLEAR MEDICINE AND BIOLOGY
- Synthesis and Characterization of the Actinium Aquo Ion
- (2017) Maryline G. Ferrier et al. ACS Central Science
- Phase I trial of zirconium 89 (Zr89) radiolabeled J591 in metastatic castration-resistant prostate cancer (mCRPC).
- (2017) Michael J. Morris et al. JOURNAL OF CLINICAL ONCOLOGY
- A comparative evaluation of the chelators H 4 octapa and CHX-A″-DTPA with the therapeutic radiometal 90 Y
- (2016) Eric W. Price et al. NUCLEAR MEDICINE AND BIOLOGY
- Spectroscopic and computational investigation of actinium coordination chemistry
- (2016) Maryline G. Ferrier et al. Nature Communications
- Evaluation of a 3-hydroxypyridin-2-one (2,3-HOPO) Based Macrocyclic Chelator for 89Zr4+ and Its Use for ImmunoPET Imaging of HER2 Positive Model of Ovarian Carcinoma in Mice
- (2016) Jeff N.Tinianow et al. Theranostics
- Macrocycle-Based Hydroxamate Ligands for Complexation and Immunoconjugation of89Zirconium for Positron Emission Tomography (PET) Imaging
- (2016) Eszter Boros et al. ChemPlusChem
- p-SCN-Bn-HOPO: A Superior Bifunctional Chelator for 89Zr ImmunoPET
- (2015) Melissa A. Deri et al. BIOCONJUGATE CHEMISTRY
- Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development
- (2015) Paresh Agarwal et al. BIOCONJUGATE CHEMISTRY
- Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications
- (2015) Sharmila Banerjee et al. CHEMICAL REVIEWS
- A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer
- (2015) N. Pandit-Taskar et al. CLINICAL CANCER RESEARCH
- Tripodal tris(hydroxypyridinone) ligands for immunoconjugate PET imaging with 89Zr4+: comparison with desferrioxamine-B
- (2015) Michelle T. Ma et al. DALTON TRANSACTIONS
- 6LBA 177-Lu-Dotatate significantly improves progression-free survival in patients with midgut neuroendocrine tumours: Results of the phase III NETTER-1 trial
- (2015) J. Strosberg et al. EUROPEAN JOURNAL OF CANCER
- Investigating the Complexation of the Pb2+/Bi3+ Pair with Dipicolinate Cyclen Ligands
- (2015) Luís M. P. Lima et al. INORGANIC CHEMISTRY
- Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody
- (2015) S. N. Rylova et al. JOURNAL OF NUCLEAR MEDICINE
- 64Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patients
- (2015) Hiroaki Kurihara et al. EJNMMI Research
- Production of iodine-124 and its applications in nuclear medicine
- (2014) Ana Maria S. Braghirolli et al. APPLIED RADIATION AND ISOTOPES
- Antibody-based imaging strategies for cancer
- (2014) Jason M. Warram et al. CANCER AND METASTASIS REVIEWS
- H2Me-do2pa: an attractive chelator with fast, stable and inert natBi3+ and 213Bi3+ complexation for potential α-radioimmunotherapy applications
- (2014) Luís M. P. Lima et al. CHEMICAL COMMUNICATIONS
- An octadentate bifunctional chelating agent for the development of stable zirconium-89 based molecular imaging probes
- (2014) Malay Patra et al. CHEMICAL COMMUNICATIONS
- Charting the mechanism and reactivity of zirconium oxalate with hydroxamate ligands using density functional theory: implications in new chelate design
- (2014) Jason P. Holland et al. DALTON TRANSACTIONS
- 89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
- (2014) Neeta Pandit-Taskar et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 213Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience
- (2014) C. Kratochwil et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Alternative Chelator for 89Zr Radiopharmaceuticals: Radiolabeling and Evaluation of 3,4,3-(LI-1,2-HOPO)
- (2014) Melissa A. Deri et al. JOURNAL OF MEDICINAL CHEMISTRY
- Theranostic applications of antibodies in oncology
- (2014) Emmy D.G. Fleuren et al. Molecular Oncology
- Comparison of Conjugation Strategies of Cross-Bridged Macrocyclic Chelators with Cetuximab for Copper-64 Radiolabeling and PET Imaging of EGFR in Colorectal Tumor-Bearing Mice
- (2014) Dexing Zeng et al. MOLECULAR PHARMACEUTICS
- 166Ho and 90Y labeled 6D2 monoclonal antibody for targeted radiotherapy of melanoma: Comparison with 188Re radiolabel
- (2014) S. Thompson et al. NUCLEAR MEDICINE AND BIOLOGY
- Feasibility of Isotope Harvesting at a Projectile Fragmentation Facility: 67Cu
- (2014) Tara Mastren et al. Scientific Reports
- Enzyme-Mediated Methodology for the Site-Specific Radiolabeling of Antibodies Based on Catalyst-Free Click Chemistry
- (2013) Brian M. Zeglis et al. BIOCONJUGATE CHEMISTRY
- Pharmacokinetics and Imaging of 212Pb-TCMC-Trastuzumab After Intraperitoneal Administration in Ovarian Cancer Patients
- (2013) Ruby F. Meredith et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Matching chelators to radiometals for radiopharmaceuticals
- (2013) Eric W. Price et al. CHEMICAL SOCIETY REVIEWS
- 64Cu-DOTA-Trastuzumab PET Imaging in Patients with HER2-Positive Breast Cancer
- (2013) K. Tamura et al. JOURNAL OF NUCLEAR MEDICINE
- H4octapa-Trastuzumab: Versatile Acyclic Chelate System for 111In and 177Lu Imaging and Therapy
- (2013) Eric W. Price et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Preclinical evaluation of NETA-based bifunctional ligand for radioimmunotherapy applications using 212Bi and 213Bi: Radiolabeling, serum stability, and biodistribution and tumor uptake studies
- (2013) Chi Soo Kang et al. NUCLEAR MEDICINE AND BIOLOGY
- Synthesis and Preclinical Evaluation of Bifunctional Ligands for Improved Chelation Chemistry of 90Y and 177Lu for Targeted Radioimmunotherapy
- (2012) Chi Soo Kang et al. BIOCONJUGATE CHEMISTRY
- Towards translation of 212Pb as a clinical therapeutic; getting the lead in!
- (2011) Kwon Yong et al. DALTON TRANSACTIONS
- Convection-enhanced delivery of131I-chTNT-1/B mAB for treatment of high-grade adult gliomas
- (2011) Alia Hdeib et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Magnitude of Enhanced Permeability and Retention Effect in Tumors with Different Phenotypes: 89Zr-Albumin as a Model System
- (2011) C. Heneweer et al. JOURNAL OF NUCLEAR MEDICINE
- In vivo biodistribution and accumulation of 89Zr in mice
- (2011) Diane S. Abou et al. NUCLEAR MEDICINE AND BIOLOGY
- Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
- (2010) Thaddeus J. Wadas et al. CHEMICAL REVIEWS
- Cetuximab-Based Immunotherapy and Radioimmunotherapy of Head and Neck Squamous Cell Carcinoma
- (2010) G. Niu et al. CLINICAL CANCER RESEARCH
- 89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo
- (2010) J. P. Holland et al. JOURNAL OF NUCLEAR MEDICINE
- Biopharmaceutical benchmarks 2010
- (2010) Gary Walsh NATURE BIOTECHNOLOGY
- Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine
- (2010) Maria J W D Vosjan et al. Nature Protocols
- Measuring the Pharmacodynamic Effects of a Novel Hsp90 Inhibitor on HER2/neu Expression in Mice Using 89Zr-DFO-Trastuzumab
- (2010) Jason P. Holland et al. PLoS One
- Hydrated metal ions in aqueous solution: How regular are their structures?
- (2010) Ingmar Persson PURE AND APPLIED CHEMISTRY
- Molecular Imaging of Cancer with Copper-64 Radiopharmaceuticals and Positron Emission Tomography (PET)
- (2009) Monica Shokeen et al. ACCOUNTS OF CHEMICAL RESEARCH
- Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs): a phase II study
- (2009) J. B. Cwikla et al. ANNALS OF ONCOLOGY
- 124I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of 131I-L19-SIP radioimmunotherapy
- (2009) Bernard M. Tijink et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Separation of Yb as YbSO4 from the 176Yb target for production of 177Lu via the 176Yb(n, γ)177Yb→177Lu process
- (2009) A. Bilewicz et al. JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY
- Standardized methods for the production of high specific-activity zirconium-89
- (2009) Jason P. Holland et al. NUCLEAR MEDICINE AND BIOLOGY
- Receptor-Binding, Biodistribution, and Metabolism Studies of 64Cu-DOTA-Cetuximab, a PET-Imaging Agent for Epidermal Growth-Factor Receptor-Positive Tumors
- (2008) Wen Ping Li et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Technetium-99m-Labelled Sulesomab (LeukoScan) in the Evaluation of Soft Tissue Infections
- (2008) Anne-Marie Quigley et al. MEDICAL PRINCIPLES AND PRACTICE
- Production of 177Lu at the new research reactor FRM-II: Irradiation yield of 176Lu177Lu
- (2007) Z. Dvorakova et al. APPLIED RADIATION AND ISOTOPES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More